SHL Medical, a Swiss provider of self-injection solutions, announced on Thursday that it is planning to establish SHL Advantec, a sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries.
SHL Advantec will be headquartered in Zug, Switzerland and will commence operations with more than 600 employees across its offices and production sites in Switzerland, China, Taiwan, Mexico and the United States.
SHL Medical's existing tooling and automation operations will be integrated into SHL Advantec, bringing its range of technologies, services and equipment portfolio to the new business. Together with SHL Medical's recent strategic acquisitions -- Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling -- SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec's diverse customer base. Leveraging its experience in medical devices and other industries, SHL Advantec says that it will focus on helping its customers advance production quality and resilience while continuing to support SHL Medical's growth in autoinjector manufacturing.
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Abbott's Navitor TAVI system granted CE Mark for expanded indication
PharmaResearch names VIVACY as European distribution partner for Rejuran
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia